Stock INVO INVO BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 17:51:42 03/05/2024 BST 		5-day change 1st Jan Change
0.905 USD -2.79% Intraday chart for INVO Bioscience, Inc. -7.52% -32.87%
04-18 Top Premarket Decliners MT
04-17 Sector Update: Health Care Stocks Retreating Late Afternoon MT

Business Summary

INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.

Number of employees: 28

Sales per Business

USD in Million2022Weight2023Weight Delta
Clinic
94.8 %
1 74.8 % 3 94.8 % +365.57%
Assisted Reproductive Technology
5.2 %
0 25.2 % 0 5.2 % -23.80%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1 100.0 % 3 100.0 % +267.38%

Managers

Managers TitleAgeSince
Steven Shum CEO
 Chief Executive Officer 55 10/10/17
Andrea Goren DFI
 Director of Finance/CFO 56 13/06/21
J. Chris Jensen CTO
 Chief Tech/Sci/R&D Officer - 30/11/20
Inger Britt Carlsson CTO
 Chief Tech/Sci/R&D Officer - 12/02/20
Michael Campbell COO
 Chief Operating Officer 66 09/10/17
April McGhee PRN
 Corporate Officer/Principal - 31/08/22
Bojan Mitrovic SAM
 Sales & Marketing - 31/01/22
Terah Krigsvold AUD
 Comptroller/Controller/Auditor - -
Barbara Levy PRN
 Corporate Officer/Principal - 13/07/21
Robert Joseph Bowdring SEC
 Corporate Secretary 55 30/09/08

Members of the board

Members of the board TitleAgeSince
Trent Davis BRD
 Director/Board Member 56 15/12/19
Barbara Ryan BRD
 Director/Board Member 64 13/09/20
Robert Joseph Bowdring SEC
 Corporate Secretary 55 30/09/08
Matthew Szot BRD
 Director/Board Member 50 12/09/20
Steven Shum CEO
 Chief Executive Officer 55 10/10/17
Rebecca Messina BRD
 Director/Board Member 52 20/04/21
Michael Campbell COO
 Chief Operating Officer 66 09/10/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,743,031 2,719,871 ( 99.16 %) 0 99.16 %

Shareholders

NameEquities%Valuation
Vanguard Group, Inc. (Subfiler)
2.184 %
54,058 2.184 % 61 086 $
Geode Capital Management LLC
1.084 %
26,826 1.084 % 30 313 $
Sabby Management LLC
0.7526 %
18,624 0.7526 % 21 045 $
Andrea Goren
0.3124 %
7,731 0.3124 % 8 736 $
UBS Securities LLC
0.2891 %
7,155 0.2891 % 8 085 $
Steven Shum
0.2392 %
5,919 0.2392 % 6 688 $
Tower Research Capital LLC
0.1998 %
4,945 0.1998 % 5 588 $
Michael Campbell
0.1486 %
3,678 0.1486 % 4 156 $
Matthew Szot
0.0792 %
1,960 0.0792 % 2 215 $
Trent Davis
0.0680 %
1,682 0.0680 % 1 901 $

Company contact information

INVO BioScience, Inc.

5582 Broadcast Court

34240, Sarasota

+

http://www.invobioscience.com
address INVO Bioscience, Inc.(INVO)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per Business

Ratings for INVO Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.931
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
INVO BIOSCIENCE, INC. Stock INVO Bioscience, Inc.
-32.87% 2.55M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.78% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.76% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.89% 69.44B
DEXCOM, INC. Stock DexCom, Inc.
+3.78% 50.37B
CENCORA, INC. Stock Cencora, Inc.
+8.52% 44.82B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.53B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.28% 26.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.74% 26.73B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.71B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. INVO Stock
  4. Company INVO Bioscience, Inc.